Introduction
Protein phosphorylation and dephosphorylation play key roles in the regulation of meiotic maturation. The maturation-promoting factor (MPF) complex with its catalytic subunit p34cdc2, a serine and threonine protein kinase, is responsible for driving the meiotic and mitotic cell cycle from G2-to M-phase (Doree, 1990; Mailer, 1990;  Nurse, 1990; Norbury and Nurse, 1992 Nurse, 1992) .
By an indirect pathway, microtubule-associated protein kinase (MAP kinase) becomes activated by phosphorylation on tyrosine (Ray and Sturgill, 1987, 1988; Gotoh el al, 1991) . Meiotic matu¬ ration of animal oocytes therefore appears to involve not only dephosphorylation of p34c a on threonine and tyrosine but also the phosphorylation of serine/threonine and tyrosine residues on other important regulatory molecules. Furthermore, mitogenic growth factors stimulate cell proliferation by pathways involving serine/threonine or tyrosine phosphorylation or both (Yarden and Ullrich, 1988) .
We report here the effects of the protein kinase inhibitor genistein on pig oocyte maturation. Genistein, which is an isoflavone, inhibits tyrosine protein kinase and protein kinase C activity and to a lesser extent other protein kinases (Akiyama et al, 1987; Geissler et al, 1990) . Genistein (Morton, 1970) supplemented with sodium pyru¬ vate (100 pg ml-1), gentamycin (25 pg ml"1), BSA (10 mg ml" ') and Pergonal (0.1 iu ml"1, Serono (Jung et al, 1992 (Besterman and Schultz, 1990 (Besterman and Schultz, 1990) . Mouse oocyte matu¬ ration is inhibited by genistein in a dose-dependent manner (ED50: 20 pg ml"1). This effect is completely reversible (Kimura et al, 1991 (Fulka et al, 1986; Kubelka et al, 1988 (Gotoh et al, 1991; Matsuda et al, 1992 
